Insys agrees to pay $4.5 million to resolve Illinois opioid lawsuit

Reuters News
Posted: Aug 18, 2017 2:35 PM

(Reuters) - Insys Therapeutics Inc has agreed to pay $4.5 million to resolve a lawsuit by Illinois' attorney general claiming it deceptively marketed a highly addictive fentanyl-based cancer pain drug for off-label uses.

The settlement, announced by Illinois Attorney General Lisa Madigan on Friday, will resolve claims that Insys illegally marketed its product Subsys to high-volume prescribers of opioid drugs instead of to oncologists treating cancer patients.

(Reporting by Nate Raymond in Boston; Editing by Leslie Adler)